Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock Price Down 0.8% – Should You Sell?

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX)’s share price dropped 0.8% during trading on Monday . The stock traded as low as $0.8124 and last traded at $0.8273. Approximately 1,101,927 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 3,063,618 shares. The stock had previously closed at $0.8340.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on QTEX. Weiss Ratings reissued a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Monday, August 24th. Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Inspira Technologies OXY B.H.N. currently has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Stock Up 1.7%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.30 and a current ratio of 1.56. The business has a fifty day simple moving average of $1.16.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has authorized a share repurchase plan on Monday, June 22nd that permits the company to repurchase 2,000,000,000,000 outstanding shares. This repurchase authorization permits the company to reacquire up to 5.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.